256
Views
2
CrossRef citations to date
0
Altmetric
Rapid Communication

Therapeutic drug monitoring of aminoglycosides in acute myeloid leukaemia patients

, , , , , , , & show all
Pages 398-401 | Received 03 Oct 2011, Accepted 27 Nov 2011, Published online: 11 Jan 2012

References

  • Furno P, Bucaneve G, Del Favero A. Monotherapy or aminoglycoside-containing combinations for empirical antibiotic treatment of febrile neutropenic patients: a meta-analysis. Lancet Infect Dis 2002;2:231–42.
  • Paul M, Soares-Weiser K, Leibovici L. Beta-lactam monotherapy versus beta-lactam-aminoglycoside combination therapy for fever with neutropenia: systemic review and meta-analysis. BMJ 2003;326:1111.
  • Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, . Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52:427–31.
  • Drgona L, Paul M, Bucaneve G, Calandra T. The need for aminoglycosides in combination with β-lactams for high-risk, febrile neutropaenic patients with leukaemia. Eur J Cancer Supp 2007;5:13–22.
  • Lortholary O, Tod M, Cohen Y, Petitjean O. Aminoglycosides. Med Clin North Am 1995;79:761–87.
  • Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of Cmax concentration to minimal inhibitory concentration. J Infect Dis 1987;155:93–9.
  • Lortholary O, Lefort A, Tod M, Chomat AM, Darras-Joly C, Cordonnier C; Club de Reflexion sur les Infections en Onco-Hématologie. Pharmacodynamics and pharmacokinetics of antibacterial drugs in the management of febrile neutropenia. Lancet Infect Dis 2008;8:612–20.
  • Commandeur D, Eyrieux S, Le Noël A, Nguyen VB, Giacardi C, Danguy des Déserts M, . Monitorage des aminosides en réanimation. Méd Mal Infect 2010;40:94–9.
  • Taccone FS, Laterre PF, Spapen H, Dugernier T, Delattre I, Layeux B, . Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock. Crit Care 2010;14:53–86.
  • Buchholtz K, Larsen CT, Hassager C, Bruun NE. Severity of gentamicin's nephrotoxic effect on patients with infective endocarditis: a prospective observational cohort study of 373 patients. Clin Infect Dis 2009;48:65–71.
  • Sung L, Dupuis LL, Bliss B, Taddio A, Abdolell M, Allen U, . Randomized controlled trial of once versus thrice-daily tobramycin in febrile neutropenic children undergoing stem cell transplantation. J Natl Cancer Inst 2003;95:1869–77.
  • Newby B, Prevost D, Lotocka-Reysner H. Assessment of gentamicin 7 mg/kg once daily for pediatric patients with febrile neutropenia: a pilot project. J Oncol Pharm Pract 2009;15:211–6.
  • Mavros MN, Polyzos KA, Rafailidis PI, Falagas ME. Once versus multiple daily dosing of aminoglycosides for patients with febrile neutropenia: a systematic review and meta-analysis. J Antimicrob Chemother 2011;66:251–9.
  • Rybak MJ, Abate BJ, Kang SL, Ruffing MJ, Lerner SA, Drusano GL. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob Agents Chemother 1999;43:1549–55.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.